当前位置:首页 - 行情中心 - 步长制药(603858) - 财务分析 - 现金流量表

步长制药

(603858)

  

流通市值:181.60亿  总市值:181.60亿
流通股本:10.55亿   总股本:10.55亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金8,100,939,408.25,751,891,144.212,929,463,148.1211,706,028,235.71
  收到的税费返还---3,522,821.59
  收到其他与经营活动有关的现金177,641,989.9793,283,141.6563,143,319.6846,748,050.14
  经营活动现金流入小计8,278,581,398.175,845,174,285.862,992,606,467.811,756,299,107.44
  购买商品、接受劳务支付的现金2,063,410,259.461,315,040,484.68526,854,643.762,860,282,382.53
  支付给职工以及为职工支付的现金747,045,197.46477,127,688.87241,722,628.451,033,775,872.62
  支付的各项税费955,721,908690,743,306.72364,147,684.171,422,258,079.79
  支付其他与经营活动有关的现金3,697,312,120.542,403,294,446.881,181,865,196.615,500,032,203.57
  经营活动现金流出的平衡项目0000.01
  经营活动现金流出小计7,463,489,485.464,886,205,927.152,314,590,152.9910,816,348,538.52
  经营活动产生的现金流量净额815,091,912.71958,968,358.71678,016,314.81939,950,568.92
二、投资活动产生的现金流量:
  收回投资收到的现金8,800,0008,800,000--
  取得投资收益收到的现金5,414,940.383,705,542.511,251,052.812,969,310.32
  处置固定资产、无形资产和其他长期资产收回的现金净额211,710240,29092,355491,704.83
  收到的其他与投资活动有关的现金4,236,249.913,093,462.11,546,364.967,535,769.77
  投资活动现金流入小计18,662,900.2915,839,294.612,889,772.7710,996,784.92
  购建固定资产、无形资产和其他长期资产支付的现金85,697,216.5462,977,434.9137,477,008.39196,995,309.52
  投资支付的现金286,924,270178,100,000302,200,00063,550,000
  支付其他与投资活动有关的现金---3,002.36
  投资活动现金流出小计372,621,486.54241,077,434.91339,677,008.39260,548,311.88
  投资活动产生的现金流量净额-353,958,586.25-225,238,140.3-336,787,235.62-249,551,526.96
三、筹资活动产生的现金流量:
  吸收投资收到的现金3,062,5002,757,5001,366,66620,890,000
  其中:子公司吸收少数股东投资收到的现金3,062,5002,757,5001,366,66620,890,000
  取得借款收到的现金1,418,800,0791,039,000,079624,000,0002,306,170,243.3
  收到其他与筹资活动有关的现金81,254,122.9280,760,129.9958,028,436.721,877,453.13
  筹资活动现金流入小计1,503,116,701.921,122,517,708.99683,395,102.722,328,937,696.43
  偿还债务支付的现金1,254,504,826.54806,502,886.48309,976,632.621,806,833,413.45
  分配股利、利润或偿付利息支付的现金512,913,054.6859,419,044.0529,779,651.85287,180,976.8
  其中:子公司支付给少数股东的股利、利润15,538,427.77--14,744,765.28
  支付其他与筹资活动有关的现金148,123,308.03125,939,959.2471,572,881.08800,133,181.83
  筹资活动现金流出小计1,915,541,189.25991,861,889.77411,329,165.552,894,147,572.08
  筹资活动产生的现金流量净额-412,424,487.33130,655,819.22272,065,937.17-565,209,875.65
四、汇率变动对现金及现金等价物的影响-8,302.28-9,965.41-42,158.2310,649.55
  现金及现金等价物净增加额平衡项目0000.01
五、现金及现金等价物净增加额48,700,536.85864,376,072.22613,252,858.13125,199,815.87
  加:期初现金及现金等价物余额817,532,973.76817,532,973.76817,532,973.76692,333,157.89
  期末现金及现金等价物余额866,233,510.611,681,909,045.981,430,785,831.89817,532,973.76
补充资料:
  净利润-590,229,183.85--702,394,653.25
  资产减值准备--2,601,071.04-977,512,390.37
  固定资产和投资性房地产折旧-238,530,337.57-403,681,531.89
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-238,530,337.57-403,681,531.89
  无形资产摊销-35,983,601.66-199,084,210.45
  长期待摊费用摊销-3,560,690.63-6,342,789.25
  处置固定资产、无形资产和其他长期资产的损失--157,220.65--427,415.37
  固定资产报废损失-102,363.27-2,045,860.56
  公允价值变动损失--3,377,528.63-149,331.32
  财务费用-56,721,190.73-122,063,506.17
  投资损失--4,570,467.9--13,020,046.98
  递延所得税-60,949,217.4--40,411,704.85
  其中:递延所得税资产减少-59,565,437.4--21,131,054.45
    递延所得税负债增加-1,383,780--19,280,650.4
  存货的减少-250,177,979.49-228,759,740.31
  经营性应收项目的减少-103,427,131.93-583,885,319.81
  经营性应付项目的增加--341,597,921.31--820,284,937.05
  现金的期末余额-1,681,909,045.98-817,532,973.76
  减:现金的期初余额-817,532,973.76-692,333,157.89
  现金及现金等价物的净增加额-864,376,072.22-125,199,815.87
公告日期2025-10-302025-08-282025-04-262025-04-26
审计意见(境内)标准无保留意见
TOP↑